user avatar
ViewRay
@viewray
ViewRay is a medical device company focused on developing a simultaneous MRI-guided adaptive radiation therapy technology for the treatment of cancer.
Denver, CO
viewray.com
Joined April 2014
637
Following
2,068
Followers
Posts
  • user avatar
    ViewRay
    @viewray
    Feb 16, 2022
    Amar Kishan, M.D., Chief of GU Radiotherapy at @UCLAJCCC, will host a LIVE Twitter Q&A to discuss interim findings from UCLA's Phase III randomized MIRAGE trial comparing MRI-guided vs. CT-guided SBRTfor localized prostate cancer. Post your questions @AmarUKishan using #MIRAGEQA
  • user avatar
    ViewRay
    @viewray
    Mar 10, 2022
    SCIMITAR initial toxicity results were presented by @UCLAHealth resident, @MartinMaMDPhD during #ACRO2022 today. Listen to @AmarUKishan summarize the favorable toxicity profile of post-prostatectomy SBRT for prostate cancer. #MRIdianSMART #ACRO2022 @HimanshuNagarMD
    00:00
  • user avatar
    ViewRay
    @viewray
    Oct 18, 2022
    ViewRay launches phase III pancreatic cancer study to demonstrate superior overall survival for patients receiving MRI-guided ablative radiation therapy. Read the press release here: lnkd.in/gkT2Wz2t
  • user avatar
    ViewRay
    @viewray
    Jan 24, 2022
    Congrats to Dr. John Michael Bryant @MoffittCancerCenter, who received a Merit Award during @ASCO GI 2022
    00:00
  • user avatar
    ViewRay
    @viewray
    Sep 20, 2022
    MD Anderson Cancer Center selects ViewRay to expand MR-guided radiation therapy program. Read the press release here: lnkd.in/g2TK577t
  • user avatar
    ViewRay
    @viewray
    Sep 1, 2020
    It's a milestone day! Together with clinicians from around the world, we have provided MRIdian MRI-guided radiation therapy to 10,000 patients. Advancing #CancerCare and treatment options! #SmartMRIdian #MorePatients #MoreProof #MorePromise @WashURadOnc
    prnewswire.com
    10,000th Patient Receives Treatment with ViewRay's MRIdian System
    /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian® MRI-Guided Radiation...
  • user avatar
    ViewRay
    @viewray
    Oct 18, 2022
    We are excited to announce the launch of LAP-ABLATE (NCT05585554), a phase III randomized control trial comparing stand-alone chemo for locally advanced pancreatic cancer to a combination of chemo and 5-fraction #MRIdianSMART. Learn more from @MikeChuongMD
    00:00
  • user avatar
    ViewRay
    @viewray
    Dec 15, 2021
    #MRIdianSMART prnewswire.com/news-releases/…
  • user avatar
    ViewRay
    @viewray
    Mar 5, 2022
    Congratulations to this guy! Resident Robert Hawranko from Virginia Commonwealth University who was awarded "Best Physics Abstract " yesterday during #RSS2022
  • user avatar
    ViewRay
    @viewray
    Jul 19, 2017
    Congrats @HenryFordNews on treating first patients on #MRIdianLinac Shout out -VR team for making #MRguidedRT happen bit.ly/2uD750h
  • user avatar
    ViewRay
    @viewray
    Oct 24, 2021
    Coming in hot at #ASTRO2021. Come by ViewBooth #1003 to experience the future of MgRT. #MRIdianSMART cvent.me/LbzN9G
  • user avatar
    ViewRay
    @viewray
    Sep 11, 2019
    We love seeing @GenesisCare Oxford's "Coming Soon" signage that informs passersby of the targeted MRI-guided #radiotherapy system under installation. It will be the first #MRIdian in the U.K. #cancertreatment #MRgRT #MRLinac @UniofOxford @PaulGearing1
  • user avatar
    ViewRay
    @viewray
    Oct 5, 2022
    More big news for #MRgRT coming out of #ASTRO22! Catch @AmarUKishan on Weds, Oct 26 reviewing the primary endpoint analysis of the #MIRAGEtrial for #prostatecancer. We’ll see you at 11 AM!
  • user avatar
    ViewRay
    @viewray
    Sep 12, 2019
    Announced today! We are honored to have @StanfordHealth place an order for a #MRIdian MRI-guided radiation therapy system - a new paradigm in #cancer treatment. #innovation #MRLinac #MRgRT #StanfordMedicine @StanfordCancer Learn more: ow.ly/CwK350w7IKl